Electronic structure of 4H-pyrido[1,2-a]pyrimidin-4-ones

The characteristic features of ir and uv spectra of 43 4H-pyrido[1,2-a]pyrimidin-4-one derivatives with electron donor or acceptor groups in position 3, and positions 6, 7, 8, or 9, respectively, have been systematically studied. On the basis of the spectra some conclusions have been drawn for the molecular structure. The negative solvent effect of the lowest-energy π π* transition is investigated by the PPP method.

[1]  F. Dessy,et al.  Nitrogen bridgehead compounds. Part 18. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. Part I , 1982 .

[2]  C. Niemegeers,et al.  A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. , 1982, The Journal of pharmacology and experimental therapeutics.

[3]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[4]  E. Hidvégi,et al.  Effect of CH-1243, a pyrido (1,2-a) pyrimidine derivative on the elevated activity of lysosomal enzymes of rabbit aorta and liver in experimental atherosclerosis. , 1981, Atherosclerosis.

[5]  K. Simon,et al.  The crystal and molecular structure of 3-carbethoxy-4-oxo-6-methylhomopyrimidazole, C12H12N2O3 , 1972 .

[6]  R. S. Grewal,et al.  Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines. , 1972, Biochemical pharmacology.

[7]  R. S. Grewal,et al.  Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine. , 1971, Journal of medicinal chemistry.

[8]  R. Adams,et al.  Ultraviolet Spectra and Structures of the Pyrido [1,2-a]pyrimidones , 1952 .

[9]  N. S. Bayliss.  The Effect of the Electrostatic Polarization of the Solvent on Electronic Absorption Spectra in Solution , 1950 .

[10]  G. R. Lappin.  Cyclization of 2-aminopyridine derivatives; substituted ethyl 2-pyridylamino-methylenemalonates. , 1948, Journal of the American Chemical Society.

[11]  I. Bitter,et al.  Nitrogen bridgehead compounds. 38. 1 New antiallergic 4h-pyrido[l,2-a ]pyrimidin-4-ones. 32 , 1983 .

[12]  P. Janssen.  5-HT2 receptor blockade to study serotonin-induced pathology , 1983 .

[13]  P. Surján,et al.  Nitrogen bridgehead compounds. Part 32. Absolute configuration and circular dichroism of 6-methyl-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-ones , 1983 .

[14]  Á. Kiss,et al.  Electron structure investigation of 3-iodo-5-nitro-4-hydroxybenzonitrile and some of its derivatives , 1983 .

[15]  F. Dessy,et al.  Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats. , 1982, International archives of allergy and applied immunology.

[16]  I. Hermecz,et al.  Nitrogen bridgehead compounds. Part 5. Cyclization of 2-(2- pyridylaminomethylene)-succinates and -glutarates , 1978 .

[17]  I. Hermecz,et al.  Nitrogen bridgehead compounds. Part 4. 1 → 3 N→C-acyl migration. Part 2 , 1977 .

[18]  G. Fogarasi,et al.  Investigation of frequency coupling in the IR spectra of 4H-pyrido(1,2a)pyrimidin-4-one derivatives , 1977 .

[19]  I. Hermecz,et al.  Reactivity of the pyrido[1,2-a]pyrimidin-4-one ring system , 1974 .